145 related articles for article (PubMed ID: 14990409)
1. Impact of folic acid fortification in the United States: markedly diminished high maternal serum alpha-fetoprotein values.
Evans MI; Llurba E; Landsberger EJ; O'Brien JE; Harrison HH
Obstet Gynecol; 2004 Mar; 103(3):474-9. PubMed ID: 14990409
[TBL] [Abstract][Full Text] [Related]
2. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.
CMAJ; 1994 Jul; 151(2):159-66. PubMed ID: 7518734
[TBL] [Abstract][Full Text] [Related]
3. Neural tube defect rates before and after food fortification with folic acid.
Mills JL; Signore C
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):844-5. PubMed ID: 15468072
[TBL] [Abstract][Full Text] [Related]
4. Survival of infants with neural tube defects in the presence of folic acid fortification.
Bol KA; Collins JS; Kirby RS;
Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
[TBL] [Abstract][Full Text] [Related]
5. [Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report].
Meijer WM; de Walle HE
Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2561-4. PubMed ID: 16320666
[TBL] [Abstract][Full Text] [Related]
6. [Fortification of food with folic acid diminishes the number of neural tube defects].
Brouwer IA
Ned Tijdschr Geneeskd; 2008 Jan; 152(4):185-6. PubMed ID: 18320941
[TBL] [Abstract][Full Text] [Related]
7. Elevated maternal serum alpha-fetoprotein values. How low is high?
Lenke RR; Guerrieri J; Nemes JM; Kurczynski TW; French B; Gray M; Schut H; Ashwood ER
J Reprod Med; 1989 Aug; 34(8):511-6. PubMed ID: 2478705
[TBL] [Abstract][Full Text] [Related]
8. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study.
Canfield MA; Collins JS; Botto LD; Williams LJ; Mai CT; Kirby RS; Pearson K; Devine O; Mulinare J;
Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):679-89. PubMed ID: 16240378
[TBL] [Abstract][Full Text] [Related]
9. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
10. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid.
Heseker HB; Mason JB; Selhub J; Rosenberg IH; Jacques PF
Br J Nutr; 2009 Jul; 102(2):173-80. PubMed ID: 19079944
[TBL] [Abstract][Full Text] [Related]
11. Reduction in orofacial clefts following folic acid fortification of the U.S. grain supply.
Yazdy MM; Honein MA; Xing J
Birth Defects Res A Clin Mol Teratol; 2007 Jan; 79(1):16-23. PubMed ID: 17177274
[TBL] [Abstract][Full Text] [Related]
12. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid.
Robbins JM; Tilford JM; Bird TM; Cleves MA; Reading JA; Hobbs CA
Pediatrics; 2006 Sep; 118(3):906-15. PubMed ID: 16950980
[TBL] [Abstract][Full Text] [Related]
13. [Folic acid and prevention of neural tube closure defects: the question is not solved yet].
Vidailhet M; Bocquet A; Bresson JL; Briend A; Chouraqui JP; Dupont C; Darmaun D; Frelut ML; Ghisolfi J; Girardet JP; Goulet O; Putet G; Rieu D; Rigo J; Turck D;
Arch Pediatr; 2008 Jul; 15(7):1223-31. PubMed ID: 18562183
[TBL] [Abstract][Full Text] [Related]
14. Neural tube defects: prevalence, etiology and prevention.
Kondo A; Kamihira O; Ozawa H
Int J Urol; 2009 Jan; 16(1):49-57. PubMed ID: 19120526
[TBL] [Abstract][Full Text] [Related]
15. The impact of MSAFP screening on genetic services, 1984-1986.
Greenberg F
Am J Med Genet; 1988 Sep; 31(1):223-30. PubMed ID: 2464932
[TBL] [Abstract][Full Text] [Related]
16. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment.
Botto LD; Lisi A; Bower C; Canfield MA; Dattani N; De Vigan C; De Walle H; Erickson DJ; Halliday J; Irgens LM; Lowry RB; McDonnell R; Metneki J; Poetzsch S; Ritvanen A; Robert-Gnansia E; Siffel C; Stoll C; Mastroiacovo P
Birth Defects Res A Clin Mol Teratol; 2006 Oct; 76(10):693-705. PubMed ID: 17029289
[TBL] [Abstract][Full Text] [Related]
17. Folate, vitamin B12 and homocysteine status in women of childbearing age: baseline data of folic acid wheat flour fortification in Iran.
Abdollahi Z; Elmadfa I; Djazayeri A; Sadeghian S; Freisling H; Mazandarani FS; Mohamed K
Ann Nutr Metab; 2008; 53(2):143-50. PubMed ID: 18997463
[TBL] [Abstract][Full Text] [Related]
18. Estimated folic acid intakes from simulated fortification of the New Zealand food supply.
Green T; Newton R; Bourn D
N Z Med J; 2003 Jan; 116(1168):U294. PubMed ID: 12607547
[TBL] [Abstract][Full Text] [Related]
19. Case for folic acid and vitamin B12 fortification in Europe.
Czernichow S; Noisette N; Blacher J; Galan P; Mennen L; Hercberg S; Ducimetière P
Semin Vasc Med; 2005 May; 5(2):156-62. PubMed ID: 16047267
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.
Williams LJ; Mai CT; Edmonds LD; Shaw GM; Kirby RS; Hobbs CA; Sever LE; Miller LA; Meaney FJ; Levitt M
Teratology; 2002 Jul; 66(1):33-9. PubMed ID: 12115778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
